MS4A6A is a new prognostic biomarker produced by macrophages in glioma patients
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.865020
Abstract: MS4A6A has been recognized as being associated with aging and the onset of neurodegenerative disease. However, the mechanisms of MS4A6A in glioma biology and prognosis are ill-defined. Here, we show that MS4A6A is upregulated in… read more here.
Keywords: analysis; macrophages glioma; ms4a6a; glioma ... See more keywords